European Patent EP3618927A1: Transient Disruption of the Blood-Retinal Barrier
EPO Patent Bulletin - Pharma (A61K)
Summary
The European Patent Office has granted patent EP3618927A1 to Sorbonne Université and Assistance Publique - Hôpitaux de Paris, covering methods for transiently disrupting the blood-retinal barrier of a human for treating a retina disorder. The patent, invented by CARPENTIER, Alexandre, is classified under IPC codes including A61K 9/00, A61K 38/00, A61P 27/02, and A61N 7/00. This grant provides exclusive rights across 35 designated EU/EEA and European states including DE, FR, GB, IT, NL, ES, and others.
“TRANSIENT DISRUPTION OF THE BLOOD-RETINAL BARRIER OF A HUMAN AND USES THEREOF FOR TREATING A RETINA DISORDER”
About this source
GovPing monitors EPO Patent Bulletin - Pharma (A61K) for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 72 changes logged to date.
What changed
The European Patent Office has granted EP3618927A1, conferring exclusive intellectual property rights to Sorbonne Université and Assistance Publique - Hôpitaux de Paris for a method of transiently disrupting the blood-retinal barrier to treat retina disorders. The patent covers therapeutic applications in the designated contracting states across the EU and EEA.
Pharmaceutical and biotechnology companies developing ophthalmological therapies should conduct freedom-to-operate analyses to ensure their products or methods do not infringe claims covered by this patent. The designated states include all major European pharmaceutical markets (DE, FR, GB, IT, NL, ES, CH, AT, BE, PL, SE, NO, DK, FI, IE, PT, CZ, HU, RO, GR, and others).
Archived snapshot
Apr 25, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
TRANSIENT DISRUPTION OF THE BLOOD-RETINAL BARRIER OF A HUMAN AND USES THEREOF FOR TREATING A RETINA DISORDER
Publication EP3618927A1 Kind: A1 Apr 15, 2026
Applicants
Sorbonne Université, Assistance Publique - Hôpitaux de Paris
Inventors
CARPENTIER, Alexandre
IPC Classifications
A61N 7/00 20060101AFI20181109BHEP A61K 9/00 20060101ALI20181109BHEP A61P 27/02 20060101ALI20181109BHEP A61F 9/007 20060101ALI20181109BHEP A61K 49/22 20060101ALI20181109BHEP A61K 38/00 20060101ALI20181109BHEP A61F 9/00 20060101ALI20181109BHEP A61M 37/00 20060101ALI20181109BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Related changes
Get daily alerts for EPO Patent Bulletin - Pharma (A61K)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from EPO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when EPO Patent Bulletin - Pharma (A61K) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.